| Revenue growth | 10.82% YoY in FY26; 20% guidance for FY27. |
|---|---|
| Margins | FY26 EBITDA margin at 8.55%; PAT margin at 3.87%. |
| Demand visibility | Committed sales contracts for CBG for next 8-10 years. |
| Management confidence | High on diversifying into CBG and BioFuels for long-term value. |
Growth
FY26 Revenue increased 10.82% to ₹141.5cr; EBITDA grew 6.3% to ₹12.2cr; PAT rose 15.5% to ₹5.5cr.
Outlook
Guiding 20% revenue growth for FY27. Investing ₹120cr each in CBG and BioFuel projects; ₹30cr Atrazine expansion.
Risks
Negative standalone operational cash flow; rising trade receivables due to export logistics delays and ongoing wars.
Earnings Call filed with NSE, NSE: DHANSA. Summary written with AI assistance from the document.
Dhansa Labs Ltd: key numbers
- Share price
- ₹27.00
- Market cap
- ₹72.64 Cr
- Revenue (annual)
- ₹141.5 Cr
- Net profit (annual)
- ₹5.73 Cr
- P/E (TTM)
- 12.7×Sector 37.5×
- Promoter holding
- 65.05%-5.10% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dhansa Labs Ltd
All →Dhansa Labs Annual General Meeting
Dhansa Labs Limited held its 41st Annual General Meeting on September 26, 2026, to adopt financial statements and ratify the cost auditor's remuneration.
Dhansa Labs Annual General Meeting
Dhansa Labs Limited announced the voting results for its postal ballot. Shareholders approved the alteration of the object clause, asset mortgage/disposal, and a related party transaction.
Dhansa Labs Annual General Meeting
Dhansa Labs Limited issued a notice for its Annual General Meeting scheduled for September 26, 2026. Agenda items include financial statement adoption and director reappointment.
- Value
- ₹0.01 Cr
Dhansa Labs Q1 FY27 Results: Net Profit ₹1.3 Cr, Up 8.3% YoY
Dhansa Labs Ltd reported revenue from operations of ₹30.6 Cr (+8.1% YoY) and net profit of ₹1.3 Cr (+8.3% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.3 Cr · +8.3% YoY
Dhansa Labs Earnings Call: Key Takeaways
Dhansa Labs reports FY26 revenue growth of 10.82% while aggressively pivoting into capital-intensive green energy and biofuels via new subsidiaries.
Dhansa Labs Earnings Call: Key Takeaways
Dhansa Labs (formerly Ambey Laboratories) reported strong FY26 performance with Revenue of ₹14,153.72 lakhs and PAT of ₹552.26 lakhs. The company is diversifying into Green Energy via CBG and Napier Grass projects.